Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Q: What does CUSIP 05337M104 represent in this 13F holders report?

CUSIP 05337M104 is the security identifier for AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in Q3 2020?

77 institutional investors reported AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 05337M104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Shares outstanding: 98,762,388
Total 13F shares: 31,489,522
Share change: -4,796,230
Total reported value: $158,737,955
Put/Call ratio: 79%
Price per share: $5.04
Number of holders: 77
Value change: -$40,676,485
Number of buys: 42
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 05337M104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	5.4%	5,306,570	$42,877,000	—	30 Jun 2020	13F
Avoro Capital Advisors LLC	13F	Company	4.6%	4,565,655	$36,890,000	—	30 Jun 2020	13F
Vivo Capital, LLC	13F	Company	3.6%	3,526,093	$28,491,000	—	30 Jun 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	3,126,131	$25,259,000	—	30 Jun 2020	13F
Polar Capital LLP	13F	Company	3%	2,978,915	$24,070,000	—	30 Jun 2020	13F
COWEN AND COMPANY, LLC	13F	Company	1.9%	1,907,504	$15,413,000	—	30 Jun 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.8%	1,752,218	$14,158,000	—	30 Jun 2020	13F
BRANDES INVESTMENT PARTNERS, LP	13F	Company	1.5%	1,483,627	$11,988,000	—	30 Jun 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.4%	1,338,491	$10,815,000	—	30 Jun 2020	13F
VR Adviser, LLC	13F	Company	1.1%	1,057,827	$8,547,000	—	30 Jun 2020	13F
Jeffrey L. Gendell	13F	Individual	1.1%	1,041,838	$8,418,000	—	30 Jun 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.84%	825,000	$6,666,000	—	30 Jun 2020	13F
Invesco Ltd.	13F	Company	0.74%	735,121	$5,940,000	—	30 Jun 2020	13F
J. Goldman & Co LP	13F	Company	0.66%	647,708	$5,233,000	—	30 Jun 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.57%	562,800	$4,547,000	—	30 Jun 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.54%	533,632	$4,312,000	—	30 Jun 2020	13F
Ikarian Capital, LLC	13F	Company	0.49%	487,143	$3,936,000	—	30 Jun 2020	13F
Avidity Partners Management LP	13F	Company	0.46%	457,951	$3,700,000	—	30 Jun 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.43%	427,676	$3,456,000	—	30 Jun 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.43%	426,881	$3,449,000	—	30 Jun 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.35%	349,222	$2,821,000	—	30 Jun 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.35%	343,525	$2,776,000	—	30 Jun 2020	13F
BAILARD, INC.	13F	Company	0.3%	293,000	$2,367,000	—	30 Jun 2020	13F
Tekla Capital Management LLC	13F	Company	0.24%	233,612	$1,888,000	—	30 Jun 2020	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	0.16%	159,200	$1,286,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.14%	142,915	$1,155,000	—	30 Jun 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.13%	131,017	$1,059,000	—	30 Jun 2020	13F
Calamos Advisors LLC	13F	Company	0.11%	106,776	$862,000	—	30 Jun 2020	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.1%	100,000	$808,000	—	30 Jun 2020	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.1%	97,687	$789,000	—	30 Jun 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.1%	96,414	$779,000	—	30 Jun 2020	13F
S.c.a. Candriam	13F	Individual	0.09%	85,000	$687,000	—	30 Jun 2020	13F
Keel Point, LLC	13F	Company	0.07%	72,224	$584,000	—	30 Jun 2020	13F
Graham Capital Management, L.P.	13F	Company	0.06%	63,600	$513,000	—	30 Jun 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.06%	61,986	$499,000	—	30 Jun 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.06%	57,300	$463,000	—	30 Jun 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.05%	51,550	$417,000	—	30 Jun 2020	13F
HighVista Strategies LLC	13F	Company	0.05%	51,408	$415,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	49,973	$404,000	—	30 Jun 2020	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.04%	43,919	$355,000	—	30 Jun 2020	13F
BARCLAYS PLC	13F	Company	0.04%	40,615	$328,000	—	30 Jun 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.04%	38,227	$309,000	—	30 Jun 2020	13F
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV	13F	Company	0.04%	36,200	$292,000	—	30 Jun 2020	13F
Virtu Financial LLC	13F	Company	0.03%	33,048	$267,000	—	30 Jun 2020	13F
EATON VANCE MANAGEMENT	13F	Company	0.03%	32,135	$260,000	—	30 Jun 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	27,395	$221,000	—	30 Jun 2020	13F
Quantitative Systematic Strategies LLC	13F	Company	0.03%	27,196	$220,000	—	30 Jun 2020	13F
OPPENHEIMER & CO INC	13F	Company	0.02%	22,814	$184,000	—	30 Jun 2020	13F
NORTHERN TRUST CORP	13F	Company	0.02%	21,663	$175,000	—	30 Jun 2020	13F
Engineers Gate Manager LP	13F	Company	0.02%	21,200	$171,000	—	30 Jun 2020	13F

Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q3 2020

As of 30 Sep 2020, Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,489,522 shares. The largest 10 holders included RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, Vivo Capital, LLC, Polar Capital LLP, BRANDES INVESTMENT PARTNERS, LP, COWEN AND COMPANY, LLC, RENAISSANCE TECHNOLOGIES LLC, GENDELL JEFFREY L, Ghost Tree Capital, LLC, and PURA VIDA INVESTMENTS, LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.